
Recent preclinical and population evidence shows cannabis modulates inflammatory and fibrotic processes in the liver, which is promising for treating the symptoms of hepatitis C virus.

Recent preclinical and population evidence shows cannabis modulates inflammatory and fibrotic processes in the liver, which is promising for treating the symptoms of hepatitis C virus.

A recently-discovered hepatitis C virus subtype may complicate treatment.

The risk of non-Hodgkin's lymphoma is elevated in patients with hepatitis C virus.